Akoya Biosciences
Jennifer joined Akoya Biosciences in February 2023 as General Counsel where she will oversee all company legal activities and provide strategic guidance and corporate governance oversight. Most recently, she served as General Counsel of Rubius Therapeutics, Inc., where she was responsible for overseeing and managing all of the company’s legal affairs. Prior to joining Rubius, she was Associate General Counsel for Progress Software Corporation where she oversaw the company’s corporate, securities law, and mergers and acquisitions activities. Jennifer began her legal career at the law firm of Skadden, Arps, Slate, Meagher & Flom LLP, where she represented public and private company clients in the biotechnology and pharmaceutical industries on mergers and acquisitions, securities law, and corporate governance matters.
This person is not in any offices
Akoya Biosciences
2 followers
Explore spatial biomarkers in the tissue microenvironment at single-cell resolution with our revolutionary multiplexed imaging solutions.